`
`Inventors: MURASHIMA et al.
`
`Confirmation No.2 To Be Assigned
`
`Applicant: Kanzaki Kokyukoki Mfg. Co., Ltd.
`
`Art Unit: T0 Be Assigned
`
`Application No.: T0 Be Assigned
`
`Examiner: To Be Assigned
`
`(Continuation-in—Parl oprpl. N0.
`14/550,499; Filed: November 2], 2014)
`
`Filed: Herewz‘th
`
`Title: Hydraulic Transaxle
`
`Atty. Docket: 0666.4980003
`
`Information Disclosure Statement
`
`Mail Stop Amendment
`
`Commissioner for Patents
`
`PO Box 1450
`
`Alexandria, VA 22313—1450
`
`Commissioner:
`
`Listed on accompanying IDS Form PTO/SB/OSa equivalent are documents that may be
`
`considered material to the patentability of this application as defined in 37 CPR. §1.56, and in
`
`compliance with the duty of disclosure requirements of 37 C.F.R. §§ 1.97 and 1.98.
`
`Applicant has listed publication dates on the attached IDS Form based on information
`
`presently available to the undersigned. However, the listed publication dates should not be
`
`construed as an admission that the information was actually published on the date indicated.
`
`Applicant reserves the right to establish the patentability of the claimed invention over any
`
`of the information provided herewith, and/or to prove that this information may not be prior art,
`
`and/or to prove that this information may not be enabling for the teachings purportedly offered.
`
`This statement should not be construed as a representation that a search has been made, or
`
`that information more material to the examination of the present patent application does not exist.
`
`The Examiner is specifically requested not to rely solely on the material submitted herewith.
`
`
`
`— 2 —
`
`MURASHIMA er a].
`
`Application No. T0 Be Assigned
`
`Applicant has checked the appropriate boxes below.
`
`Statement under 37 CPR. 1.704(d). Each item of information contained in this Information
`
`Disclosure Statement: (i) was first cited in any communication from a patent office in a
`
`counterpart1 foreign or international application or from the Office; and this communication
`
`was not received by any individual designated in Sec. 1.5 6(0) more than thirty days prior to
`
`the filing of this information disclosure statement; OR (ii) is a communication that was
`
`issued by a patent office in a counterpart foreign or international application or by the
`
`Office, and this communication was not received by any individual designated in Sec.
`
`l.56(c) more than thirty days prior to the filing of the information disclosure statement.
`
`Filing under 37 C.F.R. § 1.97(b). This Information Disclosure Statement is being filed
`
`within three months of the date of filing of a national application other than a continued
`
`prosecution application (CPA), OR within three months of the date of entry of the national
`
`stage as set forth in 37 C.F.R. § 1.491 in an international application, OR before the mailing
`
`date of a first Office Action on the merits OR before the mailing of a first Office Action
`
`after the filing of a request for continued examination under 37 CPR. § 1.114. No statement
`
`or fee is required.
`
`Filing under 37 C.F.R. § 1.97(c). This Information Disclosure Statement is being filed more
`
`than three months after the US. filing date AND after the mailing date of the first Office
`
`1 The term counterpart foreign patent application means that a claim for priority has been made in
`either the US. application or a foreign application based on the other, or that the disclosures of the
`US and foreign patent applications are substantively identical (cg, an application filed in the
`European Patent Office claiming the same U.K. priority as claimed in the US. application).
`
`Atty. Dkt. No. 0666.4980003
`
`
`
`- 3 -
`
`MURASHIMA et al.
`
`Application No. To Be Assigned
`
`Action on the merits, but before the mailing date of a Final Rejection, or Notice of
`
`Allowance, or an action that otherwise closes prosecution in the application.
`
`[:Ia.
`
`Statement under 37 C.F.R. § l.97(e)(1). I hereby state that each item of information
`
`contained in this Information Disclosure Statement was first cited in any
`
`communication from a foreign patent office in a counterpait foreign application not
`
`more than three months prior to the filing of this Information Disclosure Statement.
`
`37 C.F.R. § 1.97(e)(l).
`
`Statement under 37 C.F.R. § l.97(e)(2). I hereby state that no item of information in
`
`this Information Disclosure Statement was cited in a communication from a foreign
`
`patent office in a counterpart foreign application and, to my knowledge after making
`
`reasonable inquiry, was known to any individual designated in 37 C.F.R. § 1.56(c)
`
`more than three months prior to the filing of this Information Disclosure Statement.
`
`37 C.F.R. § l.97(e)(2).
`
`[:Ic.
`
`The required fee is provided through online credit card payment authorization in the
`
`amount of $ 0.00 in payment of the fee under 37 C.F.R. § 1.17(p).
`
`Filing under 37 C.F.R. § l.97(d) This Information Disclosure Statement is being filed more
`
`than three months after the US. filing date and after the mailing date of a Final Rejection or
`
`Notice of Allowance, but on or before payment of the Issue Fee. The required fee is
`
`provided through online credit card payment authorization in the amount of $ 0.00 in
`
`payment of the fee under 37 C.F.R. § l.l7(p); in addition:
`
`Atty. Dkt. No. 0666.4980003
`
`
`
`— 4 -
`
`MURASHIMA et a].
`
`Application No. T0 Be Assigned
`
`[:1 a. Statement under 37 C.F.R. § l.97(e)( 1). I hereby state that each item of information
`
`contained in this Information Disclosure Statement was first cited in any
`
`communication from a foreign patent office in a counterpart foreign application not
`
`more than three months prior to the filing of this Information Disclosure Statement.
`
`37 C.F.R. § l.97(e)(1).
`
`[j b. Statement under 37 C.F.R. § 197(c)(2). I hereby state that no item of information in
`
`this Information Disclosure Statement was cited in a communication from a foreign
`
`patent office in a counterpart foreign application and, to my knowledge after making
`
`reasonable inquiry, was known to any individual designated in 37 C.F.R. § 1.56(c)
`
`more than three months prior to the filing of this Information Disclosure Statement.
`
`37 C.F.R. § 1.97(e)(2).
`
`The patent family for one or more foreign language documents submitted herewith includes
`
`a United States patent, and other patent, in the English language. Copies of both the
`
`particular patent cited in the foreign patent office communication and the related United
`
`States or other English language patent or published application from the family list are
`
`enclosed. For the purposes of a statement under 37 CFR 1.97(e)(1), the United States or
`
`other English language patent or published application are to be construed as being cited by
`
`the foreign patent office. MPEP 609.04(b)(V).
`
`The document(s) was/were cited in a search report by a foreign patent office in a counterpart
`
`foreign application. Submission of an English language version of the search report that
`
`Atty. Dkt. N0. 06664980003
`
`
`
`— 5 -
`
`MURASHIMA et a1.
`
`Application No. To Be Assigned
`
`indicates the degree of relevance found by the foreign office is provided in satisfaction of
`
`the requirement for a concise explanation of relevance. MPEP 609.04(a)(lll).
`
`A concise explanation of the relevance of the non-English language document(s) appears
`
`below in accordance with 37 C.F.R. § 1.98(a)(3).
`
`In accordance with 37 C.F.R. § l.98(a)(2)(ii), no copies of US. patents and patent
`
`application publications cited as documents USl-US6 on the attached IDS Forms are
`
`submitted.
`
`Copies of the US l-USS documents were cited by or submitted to the Office in an IDS that
`
`complies with 37 C.F.R. § l.98(a)—(c) in Application No.14/550,499, filed November
`
`21, 2014, which is relied upon for an earlier filing date under 35 U.S.C. § 120. Thus, copies
`
`of these documents are not attached. 37 C.F.R. § l.98(d).
`
`410.
`
`It is expected that the examiner will review the prosecution and cited art in the parent
`
`Application No. 14/550,499 in accordance with MPEP 2001.06(b), and indicate in the next
`
`communication from the office that the art cited in the earlier prosecution history has been
`
`reviewed in connection with the present application.
`
`It is respectfully requested that the Examiner initial and return a copy of the enclosed IDS
`
`Forms, and indicate in the official file wrapper of this patent application that the documents have
`
`been considered.
`
`Atty. Dkt. N0. 06664980003
`
`
`
`- 6 -
`
`MURASHIMA et a].
`
`Application No. T0 Be Assigned
`
`The US Patent and Trademark Office is hereby authorized to charge any fee deficiency, or
`
`credit any overpayment, to our Deposit Account No. 19—0036.
`
`Respectfully submitted,
`
`WM
`
`
`
`1100 New York Avenue, NW.
`
`Washington, DC. 20005-3934
`(202) 371—2600
`
`52291 16”] {docx
`
`JRNE,KESSLER,GOLDST N&FoxP.L.L.C.
`
`
`6
`
`V”
`
`Mark W. Rygiel
`Attorney for Applicant
`Registration No. 45,871
`
`Atty. Dkt. No. 0666.4980003
`
`